MayTech Global Investments’s AbbVie ABBV Stock Holding History

MayTech Global Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-490	Closed	-$79.2K	–	31
2022 Q4	$79.2K	Buy	+490	New	+$75.1K	0.03%	43
2022 Q3	–	Sell	-490	Closed	-$75K	–	32
2022 Q2	$75K	Hold	490	–	–	0.02%	52
2022 Q1	$79K	Hold	490	–	–	0.02%	56
2021 Q4	$66K	Hold	490	–	–	0.01%	61
2021 Q3	$53K	Hold	490	–	–	0.01%	53
2021 Q2	$55K	Hold	490	–	–	0.01%	51
2021 Q1	$53K	Hold	490	–	–	0.01%	45
2020 Q4	$53K	Hold	490	–	–	0.01%	42
2020 Q3	$43K	Hold	490	–	–	0.01%	40
2020 Q2	$48K	Hold	490	–	–	0.02%	41
2020 Q1	$37K	Hold	490	–	–	0.02%	39
2019 Q4	$43K	Hold	490	–	–	0.02%	39
2019 Q3	$37K	Hold	490	–	–	0.02%	35
2019 Q2	$36K	Hold	490	–	–	0.02%	36
2019 Q1	$39K	Hold	490	–	–	0.02%	35
2018 Q4	$45K	Hold	490	–	–	0.03%	30
2018 Q3	$46K	Hold	490	–	–	0.02%	33
2018 Q2	$45K	Hold	490	–	–	0.03%	32
2018 Q1	$46K	Buy	+490	New	+$53.8K	0.03%	35

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

MayTech Global Investments's ABBV Position: Q1 2023 in Review

MayTech Global Investments sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 490 shares — an estimated $79.2K sold.

MayTech Global Investments first reported a position in ABBV in Q1 2018 and held it in 19 quarters. The position peaked at $79.2K in Q4 2022. 3,138 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

MayTech Global Investments reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
MayTech Global Investments sold 490 AbbVie shares in Q1 2023, an estimated $79.2K.
MayTech Global Investments first reported a position in AbbVie in Q1 2018 and held it in 19 quarters.
MayTech Global Investments's AbbVie position peaked at $79.2K in Q4 2022.
3,138 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on MayTech Global Investments's 13F filing for Q1 2023, filed 11 May 2023.